Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Moxian, Inc. (NASDAQ: MOXC) Using Social Media as a Channel to Initiate Online Purchases for Merchants

According to statistics published at ChinaDaily.com (http://nnw.fm/x8NcC), online sales in China have boomed, growing 26.2% year-on-year to reach over five trillion yuan ($751.7 billion) in 2016. With this in mind, researchers and specialists worldwide are looking at China to learn how to initiate more online purchases, but it is not just China’s developed e-commerce market […]

Marinus (NASDAQ: MRNS) Names Michael R. Dougherty to Board, Prepares to Initiate Phase 2 Studies of Ganaxolone

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), on February 1, 2017, named Michael R. Dougherty to its board. A biopharmaceutical company, Marinus is preparing to initiate phase 2 studies of ganaxolone, a drug which treats seizures and anxiety in patients suffering from epilepsy and neuropsychiatric disorders. Dougherty has more than 30 years of experience in the biopharmaceutical […]

Monster Digital, Inc. (NASDAQ: MSDI) Tapping into Fast-Growing VR Market with High-Performance Cameras, Headsets

Until recently, virtual reality was typically the stuff of science fiction, a concept so innovative and unusual that it seemed highly unlikely to become reality anytime soon. For years, the concept remained almost exclusively tied to the futuristic images depicted by movies such as TRON or The Lawnmower Man. However, with rapid technological advancements in […]

CytoDyn Inc. (CYDY) Set to Profit from Helping the HIV+

CytoDyn Inc. (OTCQB: CYDY) is set to profit from helping the HIV positive with its lead product candidate, PRO 140. The company is close to submitting a rolling Biologics License Application (BLA) for PRO 140 as a combination therapy with highly active antiretroviral therapy (HAART). The biologic has already been designated a “fast track” product […]

GreeneStone Healthcare Corp. (GRST) is “One to Watch”

GreeneStone Healthcare Corp. (OTCQB: GRST), through its subsidiaries, provides medical services in the city of Toronto and the regional municipality of Muskoka, Ontario, Canada. Located 90 minutes north of Toronto in Muskoka, GreeneStone Healthcare’s Addiction and Rehabilitation Treatments segment offers out-patient counseling, coaching, intervention, psychological assessment, and other related services. GreeneStone Muskoka employs the best […]

ChineseInvestors.com, Inc. (CIIX) Discusses Recent Achievements Driving Aggressive Plans for 2017

On Monday, January 30, 2017, Alan Klitenic, the Director of Investor Relations for ChineseInvestors.com, Inc. (OTCQB: CIIX), was interviewed by NetworkNewsWire. Mr. Klitenic described the company, and the growing underserved market it has managed to successfully tap, some of the company’s achievements over the past year, and the aggressive goals it is already pursuing for […]

 

From Our Blog

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Prepares to Produce Gold Amid Inflation’s Upward Pressure on Prices

June 29, 2026

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. Consumers in the United States have watched prices grow at a “moderate to strong pace” in recent weeks as an apparent response to the ongoing Iran War, according to federal policy makers (https://ibn.fm/h06l8), which has a potential downstream effect […]

Rotate your device 90° to view site.